These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 27538149

  • 21. Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis.
    Sellam J, Rouanet S, Hendel-Chavez H, Abbed K, Sibilia J, Tebib J, Le Loët X, Combe B, Dougados M, Mariette X, Taoufik Y.
    Arthritis Rheum; 2011 Dec; 63(12):3692-701. PubMed ID: 22127692
    [Abstract] [Full Text] [Related]

  • 22. [Effect of chemokines CXCL9 and CXCL10 on bone erosion in patients with rheumatoid arthritis].
    Zhong H, Xu LL, Bai MX, Su Y.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec 18; 53(6):1026-1031. PubMed ID: 34916676
    [Abstract] [Full Text] [Related]

  • 23. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
    Peckham H, Cambridge G, Bourke L, Sen D, Radziszewska A, Leandro M, Ioannou Y.
    Arthritis Rheumatol; 2017 Jul 18; 69(7):1387-1395. PubMed ID: 28380667
    [Abstract] [Full Text] [Related]

  • 24. Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis.
    El-Banna H, Jiman-Fatani A.
    BMC Musculoskelet Disord; 2014 Nov 19; 15():379. PubMed ID: 25406539
    [Abstract] [Full Text] [Related]

  • 25. CD45RA-Foxp3(high) activated/effector regulatory T cells in the CCR7 + CD45RA-CD27 + CD28+central memory subset are decreased in peripheral blood from patients with rheumatoid arthritis.
    Matsuki F, Saegusa J, Miyamoto Y, Misaki K, Kumagai S, Morinobu A.
    Biochem Biophys Res Commun; 2013 Sep 06; 438(4):778-83. PubMed ID: 23747721
    [Abstract] [Full Text] [Related]

  • 26. B-cell phenotype and IgD-CD27- memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis.
    Moura RA, Quaresma C, Vieira AR, Gonçalves MJ, Polido-Pereira J, Romão VC, Martins N, Canhão H, Fonseca JE.
    PLoS One; 2017 Sep 06; 12(9):e0182927. PubMed ID: 28886017
    [Abstract] [Full Text] [Related]

  • 27. Decreased regulatory T-cell frequency and interleukin-35 levels in patients with rheumatoid arthritis.
    Zhang X, Zhang X, Zhuang L, Xu C, Li T, Zhang G, Liu Y.
    Exp Ther Med; 2018 Dec 06; 16(6):5366-5372. PubMed ID: 30542496
    [Abstract] [Full Text] [Related]

  • 28. GITRL is associated with increased autoantibody production in patients with rheumatoid arthritis.
    Li L, Wen W, Jia R, Li Y, Liu X, Sun X, Li Z.
    Clin Rheumatol; 2016 Sep 06; 35(9):2195-202. PubMed ID: 27098050
    [Abstract] [Full Text] [Related]

  • 29. High titers of both rheumatoid factor and anti-CCP antibodies at baseline in patients with rheumatoid arthritis are associated with increased circulating baseline TNF level, low drug levels, and reduced clinical responses: a post hoc analysis of the RISING study.
    Takeuchi T, Miyasaka N, Inui T, Yano T, Yoshinari T, Abe T, Koike T.
    Arthritis Res Ther; 2017 Sep 02; 19(1):194. PubMed ID: 28865493
    [Abstract] [Full Text] [Related]

  • 30. Apoptotic effect of rituximab on peripheral blood B cells in rheumatoid arthritis.
    Szodoray P, Alex P, Dandapani V, Nakken B, Pesina J, Kim X, Wallis GL, Wilson PC, Jonsson R, Centola M.
    Scand J Immunol; 2004 Sep 02; 60(1-2):209-18. PubMed ID: 15238091
    [Abstract] [Full Text] [Related]

  • 31. Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis.
    Lee DM, Phillips R, Hagan EM, Chibnik LB, Costenbader KH, Schur PH.
    Ann Rheum Dis; 2009 Feb 02; 68(2):201-8. PubMed ID: 18390910
    [Abstract] [Full Text] [Related]

  • 32. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
    Liu X, Jia R, Zhao J, Li Z.
    J Rheumatol; 2009 Jun 02; 36(6):1136-42. PubMed ID: 19447936
    [Abstract] [Full Text] [Related]

  • 33. Associations of HLA-DRB1 alleles with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in northern east part of Turkey.
    Uçar F, Çapkin E, Karkucak M, Yücel B, Sönmez M, Alver A, Kaklikkaya N, Tosun M, Alemdaroğlu E, Solak M.
    Int J Rheum Dis; 2012 Dec 02; 15(6):538-45. PubMed ID: 23253237
    [Abstract] [Full Text] [Related]

  • 34. The relationships of CD8+ T cell subsets in RA patients with disease activity and clinical parameters.
    He J, Li Y, Chen J, Wu Q, Shan H, Wang X, Zhang M, Nie L, Wang Q.
    Int Immunopharmacol; 2023 Jan 02; 114():109399. PubMed ID: 36442285
    [Abstract] [Full Text] [Related]

  • 35. Soluble triggering receptor expressed on myeloid cells-1 is a biomarker of anti-CCP-positive, early rheumatoid arthritis.
    Molad Y, Ofer-Shiber S, Pokroy-Shapira E, Oren S, Shay-Aharoni H, Babai I.
    Eur J Clin Invest; 2015 Jun 02; 45(6):557-64. PubMed ID: 25832796
    [Abstract] [Full Text] [Related]

  • 36. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G, Studnicka-Benke A, Witzmann G, Höfler E, Smolen J.
    J Rheumatol; 1995 Mar 02; 22(3):406-12. PubMed ID: 7783054
    [Abstract] [Full Text] [Related]

  • 37. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
    Us D, Gülmez D, Hasçelik G.
    Mikrobiyol Bul; 2003 Mar 02; 37(2-3):163-70. PubMed ID: 14593899
    [Abstract] [Full Text] [Related]

  • 38. Calprotectin (a major leucocyte protein) is associated with the levels of anti-CCP and rheumatoid factor in a longitudinal study of patients with very early rheumatoid arthritis.
    Hammer HB, Haavardsholm EA, Kvien TK.
    Scand J Rheumatol; 2008 Mar 02; 37(3):179-82. PubMed ID: 18465451
    [Abstract] [Full Text] [Related]

  • 39. [Diagnostic value of serum anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis].
    Yang CL, Zhou YR, Zhou F, Li J.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug 02; 27(8):1277-9. PubMed ID: 17715048
    [Abstract] [Full Text] [Related]

  • 40. Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness.
    del Val del Amo N, Ibanez Bosch R, Fito Manteca C, Gutierrez Polo R, Loza Cortina E.
    Clin Exp Rheumatol; 2006 Aug 02; 24(3):281-6. PubMed ID: 16870095
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.